Raised blood lead levels in children

Lead investigator 

Dr. R Ruggles 

Email: slic@hpa.org.uk
Website: Surveillance of Lead in Children study           

Overview

• Public health interventions have succeeded in removing most sources of lead from the environment.
• A small proportion of children continue to be exposed to harmful levels of lead, usually in the home.
• Exposure to lead in children is associated with a range of adverse health effects, from sub-clinical neurodevelopmental impairment to encephalitis.
• There are no reliable data on the incidence or prevalence of clinically significant lead toxicity or the prevalence of elevated blood lead concentrations in children in the UK.
• Currently, the UK has no formal monitoring of childhood blood lead concentrations within laboratory or clinical systems and the public health response to such cases is likely to be sub-optimal.
• A recent case series indicates that significant obstacles are often encountered in the effective and timely management of cases.
• The aim of this study is to provide an estimate of the incidence of elevated blood lead concentrations in children.
• The study will provide important information on the management of cases, both clinically and in terms of the public health response.         

Duration: June 2010 – June 2012 inclusive (with follow-up until July 2013)  

Funding: Health Protection Agency        

Ethical approval: This study has been approved by the Riverside REC (Ref: 10/H0706/10) and has Section 251 NIGB permission under HPA reference (PIAG 03-(c)/2001).

Further Information    

• Study Protocol (PDF, 112KB, 2 pages)
• Questionnaire (PDF, 107KB, 10 pages)
• Follow-Up Questionnaire (PDF, 86KB, 11 pages)
• Frequently asked questions about lead poisoning in children (PDF, 41KB, 4 pages)
• FAQ for Paediatricians (PDF, 68KB, 4 pages)